文献速递自身免疫性与大疱性皮肤病

探索落叶型天疱疮各型与寻常型天疱疮中血管内皮生长因子及内皮联蛋白的原位表达

Exploring the in situ expression of vascular endothelial growth factor and endoglin in pemphigus foliaceus variants and pemphigus vulgaris.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2018-04-06

该研究采用免疫组化法检测红皮病型落叶型天疱疮(n=19)、非红皮病型落叶型天疱疮(n=17)、寻常型天疱疮(n=10)、银屑病(n=10)及健康对照(n=10)皮损中VEGF与内皮联蛋白的原位表达。红皮病型落叶型天疱疮VEGF表达高于非红皮病型落叶型天疱疮(P=0.034)和健康对照(P=0.004),与银屑病(P=0.667)及寻常型天疱疮(P=0.667)相似;各型落叶型天疱疮内皮联蛋白表达相似(P=0.700)。

要点

  • 红皮病型落叶型天疱疮VEGF表达高于非红皮病型落叶型天疱疮(P=0.034)和健康对照(P=0.004)。
  • 红皮病型落叶型天疱疮VEGF表达与银屑病(P=0.667)及寻常型天疱疮(P=0.667)相似。
  • 红皮病型落叶型天疱疮内皮联蛋白阳性率低于寻常型天疱疮(P=0.0009),与银屑病相似(P=0.133)。

核心结论

  • 红皮病型落叶型天疱疮中VEGF原位表达增高,提示自身抗体所致组织损伤触发了愈合过程,尤其在红皮病期。
  • 内皮联蛋白阳性率降低提示红皮病型落叶型天疱疮可能存在血管生成失衡。
  • 红皮病型落叶型天疱疮、寻常型天疱疮及银屑病中VEGF过表达提示这些疾病重症型存在修复过程失调。
  • 作者认为VEGF和内皮联蛋白可能作为预后标志物和未来治疗靶点,以促进落叶型天疱疮适当愈合。

研究设计与样本

  • 研究纳入红皮病型落叶型天疱疮19例(其中地方性落叶型天疱疮12例)、非红皮病型落叶型天疱疮17例、寻常型天疱疮10例、银屑病10例及健康对照10例。
  • 采用福尔马林固定石蜡包埋皮肤样本,在自动化免疫组化平台上以抗VEGF和抗内皮联蛋白作为一抗进行检测。
  • 反应性通过人工判读(0=阴性;1+=轻度;2+=强阳性)和自动化微血管分析算法两种方式评估。

主要发现

  • 红皮病型落叶型天疱疮VEGF表达高于非红皮病型落叶型天疱疮(P=0.034)和健康对照(P=0.004),与银屑病(P=0.667)及寻常型天疱疮(P=0.667)相似。
  • 非红皮病型落叶型天疱疮VEGF阳性率与健康对照相似(P=0.247),低于银屑病(P=0.049)和寻常型天疱疮(P=0.049)。
  • 红皮病型与非红皮病型落叶型天疱疮内皮联蛋白表达相似(P=0.700)。
  • 红皮病型落叶型天疱疮内皮联蛋白阳性率与银屑病相似(P=0.133),低于寻常型天疱疮(P=0.0009)。

临床怎么用

  • 原文结论指出VEGF和内皮联蛋白可能作为预后标志物和未来治疗靶点,以促进落叶型天疱疮适当愈合;原文未据此给出具体临床推荐。

局限性

  • 原文结论指出需进一步研究以确认调控落叶型天疱疮患者VEGF和内皮联蛋白表达是否有助于控制愈合过程并实现疾病缓解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Erythroderma is a severe manifestation of pemphigus foliaceus (PF), a blistering disease mediated by IgG autoantibodies against desmoglein 1. Increasing evidence supports the contribution of angiogenic mediators in the pathogenesis of erythroderma. OBJECTIVE: To evaluate the in situ expression of vascular endothelial growth factor (VEGF) and endoglin in patients with PF with erythroderma. METHODS: Formalin-fixed paraffin-embedded skin samples obtained from patients with erythrodermic PF (n = 19; 12 patients with endemic PF), non-erythrodermic PF (n = 17), pemphigus vulgaris (PV; n = 10), psoriasis (n = 10) and healthy individuals (HI; n = 10) were processed in an automated immunohistochemistry platform utilizing anti-VEGF and anti-endoglin as primary antibodies. Reactivity was evaluated both manually (0 = negative; 1+ = mild; 2+ = intense) and through an automated microvessel analysis algorithm. RESULTS: Vascular endothelial growth factor expression in erythrodermic PF was higher than in non-erythrodermic PF (P = 0.034) and in HI (P = 0.004), and similar to psoriasis (P = 0.667) and PV (P = 0.667). In non-erythrodermic PF, VEGF positivity was similar to HI (P = 0.247), and lower than psoriasis (P = 0.049) and PV (P = 0.049). Both erythrodermic and non-erythrodermic PF presented similar endoglin expression (P = 0.700). In addition, endoglin positivity during erythrodermic PF was similar to psoriasis (P = 0.133) and lower than PV (P = 0.0009). Increased expression of in situVEGF suggests that healing processes are triggered in response to tissue damage led by autoantibodies in PF, especially during erythroderma. Reduced endoglin positivity suggests that an unbalanced angiogenesis may occur during erythrodermic PF. Further studies may help to confirm if the regulation of VEGF and endoglin expression in patients with PF can contribute to control the healing process and enable disease remission. CONCLUSION: Overexpression of VEGF in erythrodermic PF as well as in PV and psoriasis points out a dysregulated repair process in severe forms of these diseases and suggests VEGF and endoglin could act as prognostic markers and future therapeutic targets to enable proper healing in PF.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Miyamoto D, Maruta CW, Santi CG, et al. Exploring the in situ expression of vascular endothelial growth factor and endoglin in pemphigus foliaceus variants and pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2018. PMID: 29489039. doi:10.1111/jdv.14903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。